All Comments by Richard Mayeux
Go to another page:
- 1
- 2
- Field Loses Another Prominent Neuropathologist, Donald Price, 87
- Plasma Aβ—First Sign of AD, But Tough to Measure Prospectively?
- Massive GWAS Meta-Analysis Digs Up Trove of Alzheimer’s Genes
- Field Loses Beloved Wizard of Glia, Ben Barres, 63
- One Thumb Up on Dietary Fat, One Down on Vitamins, Two Down on Estrogen
- Rotterdam Study Questions Links between Fat and Dementia Risk
- Presenilin-1 regulates the neuronal threshold to excitotoxicity both physiologically and pathologically.
- The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort.
- Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1.
- In vivo detection of amyloid plaques in a mouse model of Alzheimer's disease.
- Low use of analgesics in Alzheimer's disease: possible mechanisms.
- beta-amyloid (Abeta)42(43), abeta42, abeta40 and apoE immunostaining of plaques in fatal head injury.
- Presenilin 1 is linked with gamma-secretase activity in the detergent solubilized state.
- Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease.
- Neuroprotective effects of estrogen against beta-amyloid toxicity are mediated by estrogen receptors in cultured neuronal cells.